CEO

Dr. Gili Hart

Gili Hart_020_big

A biotech executive with broad experience in global regulatory strategic planning and interactions, partnering transactions with large-pharma companies, public company roadshows and financing. Dr Hart brings extensive experience in managing critical global programs ranging from preclinical work through Phase 3 clinical trials. 

Prior to SpliSense, Dr. Hart served as CEO of Mitoconix Bio (2017-2019).  She also served as General Manager of OPKO Biologics (2014 – 2017) and as VP of Pre-clinical and Clinical Pharmacology at PROLOR Biotech in 2009 -2013, following her role as a Senior Director at the company. 

 

Scroll Up Skip to content